title: Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder.
abstract: OBJECTIVE
  Animals exposed to stress exhibit a decrease in benzodiazepine receptor binding in the frontal cortex. No studies have examined central benzodiazepine receptor binding in patients with posttraumatic stress disorder (PTSD). The purpose of this study was to examine measures of benzodiazepine receptor binding in PTSD.
  
  
  METHODS
  From 13 patients with Vietnam combat-related PTSD and 13 case-matched healthy comparison subjects, a quantitative measure related to benzodiazepine receptor binding (distribution volume) was obtained with single photon emission computed tomography (SPECT) imaging of [(123)I]iomazenil binding and measurement of radioligand concentration in plasma. Distribution volume image data were analyzed by means of statistical parametric mapping.
  
  
  RESULTS
  Lower distribution volumes were found in the prefrontal cortex (Brodmann's area 9) of PTSD patients than in comparison subjects.
  
  
  CONCLUSIONS
  These findings of lower values for the benzodiazepine receptor binding measure of distribution volume are consistent with fewer benzodiazepine receptors and/or reduced affinity of receptor binding in the medial prefrontal cortex in patients with PTSD. Alterations in benzodiazepine receptor function in this area may underlie many of the symptoms of PTSD.
authors.affiliation: Deaprtment of Daignostic Radiology, Yale University School of Medicine, New Haven, CT, USA. j.bremner@yale.edu
authors.forename: J D
authors.initials: JD
authors.lastname: Bremner
authors.forename: R B
authors.initials: RB
authors.lastname: Innis
authors.forename: S M
authors.initials: SM
authors.lastname: Southwick
authors.forename: L
authors.initials: L
authors.lastname: Staib
authors.forename: S
authors.initials: S
authors.lastname: Zoghbi
authors.forename: D S
authors.initials: DS
authors.lastname: Charney
mesh_terms: D000328:Adult; D010054:Brief Psychiatric Rating Scale / Q000706:statistics & numerical data; D003130:Combat Disorders / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology; D005442:Flumazenil / Q000031:analogs & derivatives; D006624:Hippocampus / Q000000981:diagnostic imaging / Q000378:metabolism; D006801:Humans; D007457:Iodine Radioisotopes; D008297:Male; D008636:Mesencephalon / Q000000981:diagnostic imaging / Q000378:metabolism; D008875:Middle Aged; D011149:Pons / Q000000981:diagnostic imaging / Q000378:metabolism; D017397:Prefrontal Cortex / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000503:physiopathology; D011963:Receptors, GABA-A / Q000378:metabolism* / Q000502:physiology; D013788:Thalamus / Q000000981:diagnostic imaging / Q000378:metabolism; D015899:Tomography, Emission-Computed, Single-Photon / Q000706:statistics & numerical data*; D014728:Veterans / Q000523:psychology; D014744:Vietnam
chemical_list: D007457:Iodine Radioisotopes; D011963:Receptors, GABA-A; D005442:Flumazenil; C063038:iomazenil